09.17.15
French ultrasound technology developer SuperSonic Imagine has received regulatory approval in Japan for its most recent Aixplorer ultrasound scanner.
The system is being marketed in Japan by Konica Minolta Medical Imaging through an exclusive distribution agreement signed by the two firms in January 2015.
Aixplorer provides real-time shear-wave elastography to quantify tissue stiffness in a broad range of clinical applications, such as breast, liver, prostate, thyroid, and musculoskeletal assessments, according to SuperSonic Imagine. Tissue stiffness is used by doctors to help identify potentially malignant or other diseased tissue. In addition to SWE for quantifying tissue stiffness, SuperSonic Imagine's Aixplorer also provides UltraFast Doppler that combines color flow imaging and pulsed wave doppler into one exam, providing physicians with exam results simultaneously and helping to increase patient throughput.
"We are thrilled to have accomplished this regulatory approval, an important milestone that is a reflection of Konica Minolta's and SuperSonic Imagine's strong partnership," said Jacques Souquet, Ph.D., founder and chief innovation officer of SuperSonic Imagine. "This technology is positioned to revolutionize ultrasound imaging in Japan by providing physicians with detailed, real-time information in a broad range of clinical applications."
Founded in 2005 and based in Aix-en-Provence, France, SuperSonic Imagine specializes in medical imaging development. Over the last decade, the company has been supported by various investors, including Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI.
The system is being marketed in Japan by Konica Minolta Medical Imaging through an exclusive distribution agreement signed by the two firms in January 2015.
Aixplorer provides real-time shear-wave elastography to quantify tissue stiffness in a broad range of clinical applications, such as breast, liver, prostate, thyroid, and musculoskeletal assessments, according to SuperSonic Imagine. Tissue stiffness is used by doctors to help identify potentially malignant or other diseased tissue. In addition to SWE for quantifying tissue stiffness, SuperSonic Imagine's Aixplorer also provides UltraFast Doppler that combines color flow imaging and pulsed wave doppler into one exam, providing physicians with exam results simultaneously and helping to increase patient throughput.
"We are thrilled to have accomplished this regulatory approval, an important milestone that is a reflection of Konica Minolta's and SuperSonic Imagine's strong partnership," said Jacques Souquet, Ph.D., founder and chief innovation officer of SuperSonic Imagine. "This technology is positioned to revolutionize ultrasound imaging in Japan by providing physicians with detailed, real-time information in a broad range of clinical applications."
Founded in 2005 and based in Aix-en-Provence, France, SuperSonic Imagine specializes in medical imaging development. Over the last decade, the company has been supported by various investors, including Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI.